Lauren Dembeck, PhD, is a freelance science & medical writer. She specializes in medicine and healthcare, focusing on topics such as hematology, oncology, immunotherapy, and mental health care, among others. Her work has been featured in various publications, including Oncology Nurse Advisor, Infectious Disease Advisor, and Cancer Therapy Advisor.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Lauren Dembeck's articles predominantly cite data related to medical research, hematology, cancer treatment, and blood disorders. She appears to focus on scientific themes within the healthcare and pharmaceutical sector. Given her reliance on data-backed information, she may be interested in receiving pitches from researchers or professionals with access to new and significant datasets or those who can provide expert analysis of existing ones.
Lauren appears to have a broad international scope rather than a specific geographic focus. Her coverage seems centered around developments in medical research and treatments globally without being limited to any particular region.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Lauren Dembeck
Lauren Dembeck, PhD | Publish Date A urine-based assay targeting AL021918.2 and vimentin VIM ) methylation demonstrated
Nephrology referral may provide an opportunity to improve gout management among patients, particularly those with CKD.
Higher baseline levels of apoptosis-related plasma proteins may identify patients with stage 3 CKD who derive greater kidney benefit from tirzepatide.
Air pollution spikes linked to increased healthcare use among adults with CKD.
By: Lauren Dembeck
Adding rituximab to first-line chemotherapy may be a cost-effective strategy for children and young adults with Burkitt lymphoma (BL) in Tanzania, particularly those with advanced-stage disease, according to study findings published in JCO Global Oncology.
Researchers identify a calcium-driven pathway that may promote hypertension.
Patients with AKI faced significantly higher 30-day readmission rates after discharge.
Study highlights neddylation's role in regulating NCC activity and hyperkalemia.
Experimental findings connect Kir4.2 to hypertension and acid-base homeostasis.
By: Lauren Dembeck
Lauren Dembeck PhD | Publish Date Greater distance to subway stations, longer travel times, and complex transit routes were
